Anzeige der Einträge 1-1 von 1
Using GPCRs as molecular beacons to target ovarian cancer with nanomedicines
The five-year survival rate for women with ovarian cancer is very poor despite radical cytoreductive surgery and chemotherapy. Although most patients initially respond to platinum-based chemotherapy, the majority experience ...
01A - Beitrag in wissenschaftlicher Zeitschrift